The different faces of thrombotic thrombocytopenic purpura by Paul Knöbl

Get full text

Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation? by Klaus Geissler, Eva Jäger, Agnes Barna, Thamer Sliwa, Paul Knöbl, Ilse Schwarzinger, Heinz Gisslinger, Peter Valent

Get full text

Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS by Wolfgang Miesbach, Nicola Curry, Paul Knöbl, Charles Percy, Rita Santoro, Alvin H. Schmaier, Karolin Trautmann-Grill, Kayode Badejo, Jie Chen, Masoud Nouri, Pooja Oberai, Robert Klamroth

Get full text

Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life Support by Marion Wiegele, Daniel Laxar, Eva Schaden, Eva Schaden, Andreas Baierl, Mathias Maleczek, Mathias Maleczek, Paul Knöbl, Martina Hermann, Martina Hermann, Alexander Hermann, Christian Zauner, Johannes Gratz

Get full text

Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura by Silvia Ferrari, Kristina Palavra, Bernadette Gruber, Johanna A. Kremer Hovinga, Paul Knöbl, Claudine Caron, Caroline Cromwell, Louis Aledort, Barbara Plaimauer, Peter L. Turecek, Hanspeter Rottensteiner, Friedrich Scheiflinger

Get full text

THE ROLE OF ADAMTS13 ACTIVITY LEVELS ON DISEASE EXACERBATION OR RELAPSE IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA: POST HOC ANALYSIS OF THE PHASE 3 HERCU... by Johanna KREMER HOVINGA, Javier DE LA RUBIA, Katerina PAVENSKI, Ara METJIAN, Paul KNÖBL, Flora PEYVANDI, Spero CATALAND, Paul COPPO, Umer KHAN, Laurel A. MENAPACE, Ana PAULA MARQUES, Sriya GUNAWARDENA, Marie SCULLY

Get full text

Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study by Christian Herbert Burgmann, Ulrich J. Sachs, Karolin Trautmann-Grill, Christian Pfrepper, Paul Knöbl, Richard Greil, Johannes Oldenburg, Wolfgang Miesbach, Katharina Holstein, Hermann Eichler, Patrick Möhnle, Matthias Höpting, Christiane Dobbelstein, Robert Klamroth, Andreas Tiede

Get full text

LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY by Özgür Pektaş, Marie Scully, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul Knöbl, Flora Peyvandi, Spero Cataland, Paul Coppo, Johanna A. Kremer Hovinga, Jessica Minkue Mi Edou, Rui de Passos Sousa, Sriya Gunawardena, Julie Lin

Get full text